Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mainz Biomed B.V.

3.53
+0.330010.31%
Post-market: 3.50-0.0300-0.85%19:52 EDT
Volume:237.60K
Turnover:808.99K
Market Cap:10.73M
PE:-0.16
High:3.58
Open:3.24
Low:3.14
Close:3.20
Loading ...

Mainz Biomed Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
02 Apr

Mainz Biomed FY24 EPS ($22.36) Up From ($64.76) YoY; Revenue $893.9K Down From $895.4K YoY

Benzinga
·
01 Apr

Mainz Biomed reports FY24 EPS ($22.36) vs ($64.76) last year

TIPRANKS
·
01 Apr

Press Release: Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Dow Jones
·
01 Apr

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

GlobeNewswire
·
27 Mar

Strategic Collaboration and Innovative Biomarkers Drive Buy Rating for Mainz Biomed

TIPRANKS
·
21 Mar

Mainz Biomed, Liquid Biosciences Partner on Blood-Based Test for Pancreatic Cancer

MT Newswires Live
·
13 Mar

Mainz Biomed’s Breakthrough in Pancreatic Cancer Detection

TIPRANKS
·
13 Mar

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

GlobeNewswire
·
13 Mar

Mainz Biomed supports Colorectal Cancer Awareness Month

TIPRANKS
·
03 Mar

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention

GlobeNewswire
·
03 Mar

Maxim starts Mainz Biomed at Buy on CRC screening potential

TIPRANKS
·
14 Feb

Mainz Biomed, GANZIMMUN launch enhanced ColoAlert CRC screening test

TIPRANKS
·
11 Feb

Mainz Biomed regains compliance with Nasdaq Capital Market

TIPRANKS
·
27 Jan

Mainz Biomed NV trading resumes

TIPRANKS
·
15 Jan

Mainz Biomed NV trading halted, volatility trading pause

TIPRANKS
·
15 Jan

Mainz Biomed B.V. Addresses Nasdaq Listing Compliance Issue

TIPRANKS
·
15 Jan

Mainz Biomed Partners With Quest Diagnostics for Colorectal Cancer Screening Test

MT Newswires Live
·
19 Dec 2024

Mainz Biomed forms agreement with Quest Diagnostics

TIPRANKS
·
19 Dec 2024

Mainz Biomed Secures $8 Million in Follow-On Offering

TIPRANKS
·
17 Dec 2024